Data Analysis
Largest Pharmaceutical and Device Company Payments in Texas
The CMS Open Payments program requires pharmaceutical and medical device companies to disclose payments made to physicians and teaching hospitals. This analysis ranks the top companies by total payments made to providers in Texas. The top 25 companies collectively paid $640,562,373 to healthcare providers in this state.
Context: Industry payments to physicians are legally required to be disclosed under the Physician Payments Sunshine Act.
Receiving payments does not imply wrongdoing. Payments may reflect consulting expertise, research participation, or speaking engagements.
This data is provided to support transparency, not to render clinical judgments.
Top Companies by Total Payments to Texas Providers
CMS Open Payments| # | Company | Total Payments | Doctors Paid | Total Transactions |
|---|---|---|---|---|
| 1 | Arthrex, Inc. | $229,650,609 | 987 | 17,432 |
| 2 | Stryker Corporation | $40,134,863 | 7,294 | 92,102 |
| 3 | Intuitive Surgical, Inc. | $31,964,534 | 3,367 | 53,551 |
| 4 | AstraZeneca Pharmaceuticals LP | $25,930,195 | 24,895 | 293,203 |
| 5 | ABBVIE INC. | $25,461,139 | 29,697 | 386,899 |
| 6 | Lilly USA, LLC | $23,355,701 | 19,984 | 263,233 |
| 7 | Abbott Laboratories | $19,267,507 | 17,769 | 244,531 |
| 8 | Regeneron Pharmaceuticals, Inc. | $19,225,500 | 544 | 2,964 |
| 9 | Novo Nordisk Inc | $18,556,569 | 19,087 | 305,017 |
| 10 | Zimmer Biomet Holdings, Inc. | $18,018,062 | 3,535 | 19,619 |
| 11 | Medtronic, Inc. | $16,674,700 | 15,457 | 124,104 |
| 12 | DePuy Synthes Products, Inc. | $16,385,873 | 62 | 636 |
| 13 | Amgen Inc. | $16,355,864 | 22,130 | 236,545 |
| 14 | PFIZER INC. | $16,252,011 | 28,116 | 241,578 |
| 15 | GlaxoSmithKline, LLC. | $13,585,312 | 17,871 | 198,741 |
| 16 | Boston Scientific Corporation | $13,536,334 | 12,361 | 90,215 |
| 17 | AbbVie Inc. | $13,080,494 | 18,403 | 183,669 |
| 18 | GENZYME CORPORATION | $11,747,052 | 8,503 | 66,693 |
| 19 | Janssen Pharmaceuticals, Inc | $11,644,435 | 17,708 | 152,622 |
| 20 | E.R. Squibb & Sons, L.L.C. | $11,041,847 | 10,224 | 81,636 |
| 21 | Focal Therapeutics, Inc. | $10,510,893 | 56 | 98 |
| 22 | Novartis Pharmaceuticals Corporation | $9,839,494 | 18,393 | 189,212 |
| 23 | Boehringer Ingelheim Pharmaceuticals, Inc. | $9,701,003 | 15,541 | 123,252 |
| 24 | Takeda Pharmaceuticals U.S.A., Inc. | $9,425,805 | 13,642 | 100,821 |
| 25 | Gilead Sciences, Inc. | $9,216,575 | 7,000 | 57,904 |
State payment context — Texas
CMS Open PaymentsAcross 125,273 Texas providers with at least one disclosed industry payment over 2018–2024, the median provider received $411 in total payments, compared with a national median of $339 across 1,571,086 paid providers.
Texas accounts for 8.0% of the $16,205,257,917 in industry payments recorded nationwide in this database, and its per-provider median runs above the national benchmark.
Top specialties by median industry payment — Texas
| Specialty | Median per provider | Providers paid | Total payments |
|---|---|---|---|
| Hepatology Physician | $53,378 | 25 | $4,309,961 |
| Clinical Cardiac Electrophysiology Physician | $22,602 | 91 | $4,444,228 |
| Orthopaedic Foot and Ankle Surgery Physician | $18,054 | 50 | $10,073,518 |
| Orthopaedic Trauma Physician | $17,442 | 44 | $6,193,513 |
| Adult Reconstructive Orthopaedic Surgery Physician | $11,964 | 79 | $10,522,071 |
Industry payments in Texas by year
| Year | Total payments | Providers paid | Transactions |
|---|---|---|---|
| 2018 | $190,174,415 | 49,849 | 987,841 |
| 2019 | $189,968,488 | 49,874 | 954,753 |
| 2020 | $139,617,972 | 40,261 | 556,152 |
| 2021 | $164,280,431 | 64,300 | 1,087,958 |
| 2022 | $195,711,371 | 73,267 | 1,261,933 |
| 2023 | $208,716,498 | 78,850 | 1,386,672 |
| 2024 | $203,093,596 | 82,229 | 1,438,888 |
Methodology
Company payment totals aggregated from CMS Open Payments records for providers licensed in Texas. Includes all payment categories (research, consulting, speaking, meals, travel, and other). Rankings reflect cumulative payments across all available years, not annualized figures. Data source: CMS Open Payments, accessed via doctransparency.com database.